We thus conducted systemic immune checkpoint analysis with both tumour-infiltrating immune cells (CD4 T, CD8 T, Treg, and natural killer (NK) cells) and complementary antigen-presenting cells (APCs) (macrophages, DCs, and tumour cells). This evidence concerns the gene CD8A and neoplasm.